Cough and Wheeze That Ease on Days Away From Work

An adult who has spent twenty months spraying two-part polyurethane finish in a small cabinet shop describes twelve months of worsening chest tightness, dry cough, and wheeze. The first eight months in the job passed without any chest symptoms, so the latency between starting the work and the first symptom is about eight months. Symptoms then built across each working week, peak in the hours after the evening shift ends, and wake the person at about three in the morning. Weekends used to clear the chest completely, but for the past two months Monday has started with a tight chest and a cough that lingers. Reliever inhaler use has climbed from twice a month to most working days, and no inhaled corticosteroid has ever been prescribed. The reliever came from an urgent care visit ten months ago for cough after a chest infection, where no spirometry was performed and no asthma diagnosis was recorded, and refills have been issued by telephone since; those records have not yet been retrieved and are requested today, because a prior spirometry result or a prior asthma label would change both the sensitization argument and the later opinion on causation. There is no childhood asthma, no smoking, no pets, and no seasonal pattern. A cartridge respirator hangs in the spray booth but was never fit tested, and the booth extraction fan has run slowly since spring. Two coworkers have developed new cough. The visit falls on a Monday after a week of vacation, and office spirometry today is entirely normal.

Case focus#

There are three paths here, not two, and the false binary is the first thing to dismantle. The first path is to build objective proof of work-relatedness while the person is still working with the agent, on the reasoning that a serial diary and a challenge performed during a working period are hard to reconstruct once the job has ended. The second is to call this ordinary adult-onset asthma, start an inhaler, and revisit the work question only if control fails to improve, which leaves a sensitized airway in daily contact with the cause. The third path is the one current guidance supports and the rest of this record assumes: treat the asthma properly today, restrict or remove the person from the sensitizing task on clinical suspicion, and complete the objective work-up on an expedited pathway, accepting an imperfect diary rather than trading lung function for documentation. Each path costs something. Restriction on suspicion alone threatens the income of a household, and it also weakens the at-work arm of the diary and can make the causation record harder to assemble later, so it has to be paired with an expedited occupational medicine referral and challenge testing rather than issued as an isolated instruction. Deferring the question is equally costly, because sensitizer-induced asthma treated only with inhalers while contact continues progresses toward fixed airflow limitation. What is never defensible is continued contact for the sake of evidence once deterioration has been documented: at that point the monitoring stops and the restriction starts.

This analysis concentrates on what happens after the first decision. It treats handoffs, result ownership, medication reconciliation, functional recovery, and scheduled reassessment as part of the clinical intervention.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this sensitizer-induced work-related asthma analysis, the working frame must remain broad enough to compare Sensitizer-induced occupational asthma, Work-exacerbated asthma from irritants, Acute irritant-induced asthma, Hypersensitivity pneumonitis or other interstitial reaction without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: A primary care clinic with office spirometry before and after bronchodilator, loaner peak flow meters, a nurse who reviews symptom and reading diaries between visits, portal and telephone follow-up, and referral pathways to occupational medicine and to pulmonary laboratories that offer methacholine challenge, with specific inhalation challenge available only at a small number of distant referral centres and by scheduled appointment. Whether a state health department program receives reports of work-related asthma depends on the jurisdiction, since formal surveillance programs exist in a minority of states, so every reporting step in this record is conditional on local availability.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Loss of the away-from-work recovery: Symptoms that once cleared completely on weekends and now carry over into the following week indicate sustained airway inflammation rather than a transient irritant response. This shift predicts persistent airflow limitation, and it marks the point at which continued work with the sensitizing agent starts to cost lung function that removal will not fully return.
• Escalating reliever use without controller therapy: The findings available at the first visit are reliever use on most working days, waking at night, and no inhaled corticosteroid anywhere in the regimen. Reliever-only treatment carries a documented risk of severe and fatal attacks, so this needs correction at the visit where it is discovered rather than at a future appointment. The diary findings are separate and arrive later: pre-shift readings that drift downward across the working week relative to personal best, and diurnal variability that appears on working days and settles away from work.
• Severe reaction after an accidental release: A container failure, spill, or ventilation breakdown followed by an hour of breathlessness, repeated reliever treatments, or symptoms that persist for weeks afterward suggests an acutely irritated and highly reactive airway. It calls for same-day assessment and removal from that process before any further shift, because sensitized airways can respond violently to quantities that were previously tolerated, and because a scheduled monitoring period is never a reason to send someone back to the task.
• Severe attack, and the life-threatening features that outrank it: Speaking in single words, sitting forward, using neck and shoulder muscles to breathe, a peak flow below half of personal best, or oxygen saturation under 92 percent identifies a severe attack that needs urgent treatment and assessment rather than another reliever dose and a wait at home. A silent chest on auscultation, drowsiness, confusion, exhaustion, or a feeble respiratory effort marks a life-threatening attack, a different grade with a different response: these mandate immediate emergency transport with treatment started during transfer rather than assessment first.
• Coworkers with matching symptoms: New cough, wheeze, or chest tightness in others working the same process points to an uncontrolled workplace hazard rather than one person's susceptibility. It raises the probability that a true sensitizer is present, and it converts the problem from an individual diagnosis into a reporting and workplace evaluation obligation before more workers become sensitized.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Sensitizer-induced occupational asthma#

What supports it. New asthma in an adult with no childhood history, arising after twenty months of regular work with a recognized low molecular weight sensitizer and after eight symptom-free months in that job, with symptoms that intensify across the working week, peak after the shift, wake the person at night, and previously cleared on days off, is the defining pattern. That eight month latency before the first symptom fits immunologic sensitization, and the loaner diary showing variability that appears at work and settles away from it supplies the physiologic link.

What argues against it or keeps uncertainty open. A person who was already asthmatic before the job, whose symptoms track pollen counts or infections rather than shifts, or whose readings vary identically at home and at work would argue against sensitization. Normal spirometry after time away is not evidence against it, and negative specific IgE testing is unhelpful for diisocyanates, so neither finding closes the question.

Discriminating next step. Obtain serial peak flow readings four times daily across at least two working weeks and two weeks away, paired with symptom and reliever records, and add nonspecific bronchial responsiveness testing while the person is still working when that is safe to do. Where deterioration forces restriction first, test promptly afterward and accept the reduced yield rather than prolonging contact. Refer for specific inhalation challenge when the diagnosis remains contested and the consequences of removal are high.

Work-exacerbated asthma from irritants#

What supports it. Pre-existing or concurrent asthma that worsens with cold air, dusts, solvent vapors, physical exertion, or poor ventilation at work is far more common than sensitizer-induced disease, and it produces the same report of feeling worse at work. Slow extraction and solvent-heavy air in a small booth would aggravate any asthmatic airway regardless of sensitization.

What argues against it or keeps uncertainty open. This person worked eight months in the job before any chest symptom appeared, and had no asthma before the job began, both of which are difficult to reconcile with worsening of pre-existing disease, which typically shows no latency at all. Symptoms that persist and intensify overnight after the shift, and progressive loss of weekend recovery, fit sensitization better than a simple irritant response that usually settles once the person leaves the irritant.

Discriminating next step. Reconstruct the respiratory history before this job from the urgent care record, prior prescriptions and refill dates, and school or sports history rather than recall alone, and do this at the first visit rather than after the diary. The distinction matters because irritant aggravation may be managed with control measures and continued work, while sensitization generally requires complete removal from the agent.

Acute irritant-induced asthma#

What supports it. A single high-level inhalational event, such as the hardener container failure, can produce persistent asthma symptoms and bronchial hyperresponsiveness beginning within hours and continuing for months, with no latency period and no immunologic mechanism required.

What argues against it or keeps uncertainty open. Symptoms here predate the container failure by about a year and followed a gradual work-linked course after an eight month latency, so a single event cannot account for the original illness. The release more plausibly represents a severe reaction in an already sensitized airway rather than the origin of the disease.

Discriminating next step. Fix the chronology precisely, using the job start date, the date of the first symptom, the diary start date, the incident record, and the dates of reliever refills, because determinations of cause and choice of control measures both hinge on whether disease began with an event or with cumulative work contact. Document the incident regardless, since on its own it mandates workplace evaluation.

Hypersensitivity pneumonitis or other interstitial reaction#

What supports it. Work-linked breathlessness and cough with a latency period can reflect an alveolar rather than airway process, particularly where contact with metalworking fluid aerosols, molds, or certain chemical agents occurs. Systemic features such as fever, weight loss, and fatigue several hours after a shift would support it. Isocyanates are capable of provoking both an airway and an alveolar reaction, so the two are not mutually exclusive.

What argues against it or keeps uncertainty open. Wheeze, reversible diurnal variability on peak flow, night waking with chest tightness, and a strong reliever response point to variable airflow obstruction rather than parenchymal inflammation, and the absence of fever, crackles, or hypoxemia on exertion reduces this branch further. A positive airway work-up does not fully close it, however, since an alveolar reaction to the same agent can develop alongside or after the airway disease.

Discriminating next step. Listen for inspiratory crackles, check oxygen saturation with walking, and obtain chest imaging with diffusing capacity if constitutional symptoms, crackles, or a restrictive pattern appear at any point, including after removal. Do not order these routinely when the diary and challenge results already point to a variable airway process.

Inducible laryngeal obstruction#

What supports it. Throat tightness triggered by strong odors, solvent smells, and fumes at work, with inspiratory stridor, difficulty getting air in rather than out, abrupt onset and offset, and a poor response to reliever inhalers, can closely imitate work-related asthma and often coexists with it.

What argues against it or keeps uncertainty open. Nocturnal waking hours after leaving the workplace, expiratory wheeze, a documented reliever response, measurable diurnal peak flow variability, and a positive methacholine challenge all favor lower airway disease. Purely laryngeal obstruction would not usually produce these objective findings.

Discriminating next step. Ask specifically about the location and phase of the difficulty and about voice change during episodes, and consider laryngoscopy during a provoked episode when symptoms persist after removal from the agent or when treatment fails to match the objective findings.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Structured occupational and temporal history, with retrieval of prior records. The diagnosis begins with the work itself: every task performed, every product handled, the safety data sheets for each, the ventilation and its maintenance, whether respiratory protection was fit tested and medically cleared, the date the job started, the date symptoms started, and how symptoms move across shifts, weekends, and vacations. Coworker symptoms and any accidental release belong in the same record. Where a reliever inhaler is already in use, request the prescribing record at this visit rather than later, since a prior spirometry result or a recorded asthma label changes the interpretation. Interpretation: A latency period of months, here about eight, followed by symptoms that intensify through the week and settle away from work identifies a sensitizer pattern, while symptoms that begin immediately in any dusty or fume-filled setting suggest irritant aggravation. A named agent on a safety data sheet converts a suspicion into a testable hypothesis and directs which immunologic testing is worth doing. A prior record showing asthma before the job began would move the case toward work-exacerbated asthma instead.
• Spirometry timed against the work schedule. Spirometry with bronchodilator response documents airflow obstruction and its reversibility, but its yield depends entirely on when it is done. A test performed after a week away measures the airway at its best and says little about how it behaves during a working week. Interpretation: Normal spirometry on a Monday after vacation neither confirms nor excludes anything and must not be recorded as a negative result. Define obstruction against the lower limit of normal for the reference equation, meaning an FEV1 to FVC ratio below the fifth percentile or a z-score below minus 1.645, rather than against a fixed ratio of 0.70. Apply the 2021 ERS and ATS criterion for bronchodilator responsiveness, an increase in FEV1 or FVC greater than 10 percent of the predicted value, and note that the older rule of a 12 percent rise from baseline together with 200 mL will classify some results differently. A reduced ratio that fails to respond after months of continued work raises concern for fixed airflow limitation and argues for faster removal.
• Serial peak flow diary across work and leave. Readings taken four times daily for at least two weeks working and two weeks away, recorded as the best of three efforts alongside symptoms and reliever doses, are the practical cornerstone of the diagnosis in most settings. Consensus and guideline sources treat this record as a test that increases diagnostic certainty, and it is also the document a later reviewer will read. The at-work arm runs under a stated stopping rule, so it is bounded by a safety threshold rather than by the calendar. Interpretation: Treat mean daily diurnal variability above 10 percent in an adult as supportive rather than diagnostic, and read the twenty-two percent recorded on working days here against that anchor. A downward drift in pre-shift readings across a working week and recovery within days of leaving support a work relationship, and a clear difference between working and non-working periods matters more than any single value. A diary with too few readings, only tidy values, or no away period is uninterpretable, so incomplete records should be repeated with support rather than read optimistically. Controller therapy started before the diary raises the whole curve and is accounted for when reading it.
• Nonspecific bronchial responsiveness testing, with its prerequisites. Methacholine challenge measures airway hyperresponsiveness and is most informative when performed while the person is still working and again after a defined period away from the agent. It also helps when the diary is equivocal or when spirometry stays normal. It is not a test to run during deterioration: it requires baseline lung function adequate for challenge, no severe attack or acute inhalational reaction in the preceding weeks, appropriate withholding of short-acting and long-acting bronchodilators to the intervals in the technical standard, and a setting where treatment for a provoked reaction is immediately at hand. Interpretation: State the cut-off used and express the result as a provocative dose rather than a concentration, since dose is less dependent on device and protocol. A PD20 at or below the standard threshold for the protocol used indicates hyperresponsiveness, and lower values indicate a greater degree of it. A positive challenge during a working period with clear improvement after time away supports a work relationship. A negative challenge while the person is actively working makes current asthma unlikely and should redirect the evaluation, whereas a challenge performed after months away, or while inhaled corticosteroid therapy is running, can be negative in genuine occupational asthma and cannot exclude it. Deterioration defers the test and prompts removal from the agent rather than a faster booking.
• Immunologic testing and referral for challenge. Skin testing and specific IgE assays can confirm sensitization to high molecular weight agents such as flour, enzymes, latex, and animal proteins, and specific IgE to an isocyanate conjugate is worth ordering for the asymmetric information it carries. Specific inhalation challenge in a referral laboratory remains the reference standard when the diagnosis is contested, the agent is unusual, or the consequences of removal are severe, and it is available at only a small number of centres, so referral is planned early rather than assumed to be local. Interpretation: Positive specific IgE to a workplace protein strongly supports sensitization, and a positive result to the relevant isocyanate conjugate likewise supports sensitization to that agent. A negative result for a low molecular weight chemical such as a diisocyanate carries almost no weight and must not be presented as evidence against the diagnosis. That asymmetry, informative when positive and uninformative when negative, is precisely what makes the test worth ordering and what must be explained before it is sent.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

The normal Monday spirometry is interpreted as expected after a week away rather than as reassurance. At that first visit, and before any diary is issued, low dose inhaled corticosteroid with formoterol is started as both maintenance and reliever therapy, inhaler technique is watched and corrected in the room, and a written action plan with named peak flow and reliever thresholds is given. The plan carries a pre-agreed stopping rule: night waking on two consecutive nights, more than six reliever actuations in any single day, or any pre-shift reading below eighty percent of personal best halts the at-work part of the monitoring, prompts a same-day clinic contact, and moves the person off spraying until reviewed. Only then does the person go home with a peak flow meter, written instruction to record the best of three efforts four times daily, and a paired symptom and reliever log, with two weeks at work and two weeks of scheduled leave planned around it. Because controller therapy is now running, the diary is read for the shape of the work pattern rather than for absolute severity, and better overall control that still leaves the work-linked swings intact supports rather than weakens the work interpretation. The first working week shows diurnal variability reaching twenty-two percent on working days and pre-shift readings drifting downward across the week, with both settling within four days of leave. In the second working week the shop assigns extra spray hours to cover a rush order, night waking occurs on consecutive nights, and a lid failure on a hardener container triggers an hour of breathlessness that needs three reliever treatments. That release brings the person in the same day rather than at the next scheduled visit, and the stopping rule has by then been met twice over, so the at-work diary ends there, a short course of oral corticosteroid is given for the acute reaction, and a written restriction from all spraying work is issued that day rather than after the results are complete. Recording continues away from the agent. Methacholine challenge is deferred for three weeks, until the acute reaction has settled and baseline lung function is adequate for testing, and is then positive at a low provocative dose, reported as a PD20 under the current bronchial challenge technical standard. Testing after restriction lowers the yield, and that trade is accepted deliberately, because the diary already carries the work link and deterioration outranks documentation. Specific IgE testing is unrevealing, which is expected for a low molecular weight agent and does not weaken the case. Occupational medicine review of the product safety data sheets identifies hexamethylene diisocyanate, confirms sensitizer-induced occupational asthma, and finds neither a written respiratory protection program nor any fit testing or medical clearance. Removal from all spraying work is made permanent, the diary, spirometry, challenge results, safety data sheets, incident record, and a dated written opinion on causation are compiled and given to the person, the case is reported where work-related asthma is reportable, and the two symptomatic coworkers are invited in. Six months after removal the person is symptom free on maintenance low dose inhaled corticosteroid with formoterol, yet repeat methacholine challenge still shows heightened airway responsiveness, so the plan shifts from cure to indefinite surveillance.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Treat the asthma properly at the first visit. Start inhaled corticosteroid containing therapy rather than a reliever alone, because reliever-only treatment is associated with severe and fatal attacks and current strategy guidance no longer supports it for any adult with asthma. For an adult with symptoms on most days and waking at night, the preferred track is low dose inhaled corticosteroid with formoterol used as both maintenance and reliever, started at the maintenance-and-reliever step rather than at as-needed treatment alone, with a step up to the medium dose if control is not established. The alternative track, for use where that combination is unavailable, not tolerated, or not affordable, is a daily inhaled corticosteroid with a separate short-acting reliever, which depends on adherence to a maintenance inhaler the person must take when feeling well. Check inhaler technique in the room, provide a written action plan with named peak flow and reliever thresholds, and review triggers, comorbid rhinitis, and vaccination status. Reassess within two to four weeks at this symptom burden rather than at the usual two to three month interval, and hold any step down until control has been stable for two to three months. Objective testing for work relatedness proceeds alongside treatment, since leaving a person undertreated while evidence is assembled is indefensible.
• Match the escalation to the severity in front of you. Name the thresholds rather than gesturing at correction. A short course of oral corticosteroid, at the dose and duration in current strategy guidance, is indicated after an acute inhalational reaction that needs repeated reliever treatments, when peak flow stays below sixty percent of personal best, or when symptoms do not settle within 48 hours of increased reliever use. Same-week rather than routine review is warranted by waking at night on most nights, reliever use on most days, or readings between sixty and eighty percent of best. Emergency assessment on the day is warranted by a reading below half of personal best, breathlessness that limits speech to single words, oxygen saturation under 92 percent, or any life-threatening feature, and these are the thresholds a person acts on from the action plan rather than waiting for a clinic call back.
• Arrange complete removal from the sensitizing agent. Once sensitizer-induced occupational asthma is established, consensus and guideline sources call for complete cessation of contact with the causative agent, because reduced contact, task rotation, or a respirator alone leaves many people with continuing symptoms and deteriorating lung function. Sensitized airways can react to concentrations far below any occupational limit. Removal means reassignment away from the process or a change of workplace, arranged with written medical restrictions, and it starts on clinical suspicion when deterioration is documented rather than waiting for the last test result.
• Create the record, then point to the right authority. The clinician's duty here is documentary, not procedural: compile and date the diary, spirometry, challenge results, safety data sheets, incident record, and a clear written opinion on causation at the time they are generated, since any later determination will rest on contemporaneous records rather than recollection. Give the person copies. Direct questions about filing requirements, benefits, and time limits to the jurisdiction's compensation authority or a qualified representative, which is their expertise and not the clinic's. Where work-related asthma is reportable in the jurisdiction, notify the state health department so that surveillance can prompt an evaluation of the workplace itself.
• Push the hazard control upstream. Individual removal protects one worker and leaves the process intact, so the response must reach the workplace and must follow the hierarchy in order: substitution of a less hazardous finish where possible, then enclosed and properly maintained spray booths with verified extraction, then respiratory protection as the last layer rather than the first. Where respirators are used at all, federal respiratory protection rules require a written program, fit testing, and medical evaluation before use, none of which existed here. Invite symptomatic coworkers for assessment and support a workplace evaluation, because sensitized workers accumulate silently around an uncontrolled process.
• Sustain surveillance after the job ends. Removal stops progression but often does not cure. Many people retain bronchial hyperresponsiveness and need continuing controller therapy, so schedule symptom review, spirometry, and treatment reassessment at defined intervals over years rather than discharging at the point of removal. Watch also for the consequences of the diagnosis itself, including lost income and low mood, and confirm that a named clinician owns each pending result and the next appointment.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain at the first visit that the pattern is suspicious enough to investigate properly but not yet proven, that treatment starts today regardless, and that the diary is the instrument that will settle the work question, so honest recording of poor readings matters more than tidy ones. Show how to use the meter, record the best of three blows, and note symptoms and reliever doses beside each entry, then read the stopping rule aloud and confirm the person can repeat back what triggers a call and what stops the at-work recording. Name the stakes out loud rather than delivering a verdict later: if this is sensitizer-induced asthma, the recommendation will be to stop working with the agent altogether, which has income consequences, and the records being created and dated now are what any later determination will rest on. Ask what the person fears most about that outcome, and answer it directly. Arrange qualified interpretation rather than relying on a family member or a coworker to translate, since the words needed here include hardener, sensitizer, fit testing, and medical work restriction. Agree in writing who reviews the diary, by what date, and how the result will be communicated.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Give a written action plan with explicit numbers matched to the reliever strategy in use. On inhaled corticosteroid with formoterol as the reliever, count actuations: more than one a day averaged across a week, or more than six in any single day, triggers a clinic call, and eight or more in a day means same-day contact and no further work with the agent, with the daily maximum for the combination never to be exceeded. On the alternative track with a short-acting reliever, the older criterion of use more than twice a week outside work applies instead. Night waking, or a peak flow below eighty percent of personal best, triggers a call on either track, while a reading below half of personal best, speech limited to single words, or drowsiness means emergency care immediately.
• Instruct the person to seek same-day assessment after any spill, ventilation failure, or accidental release with breathlessness, and to stay away from that process until reviewed, because a sensitized airway can respond severely to a quantity previously tolerated. A monitoring period already under way is not a reason to complete the working week first.
• Write the stopping rule into the plan before the diary starts, so that monitoring is bounded by a safety threshold rather than by the calendar, and state plainly that meeting it ends the at-work recording and moves the person off the task rather than earning a note in the diary.
• Name who reviews the peak flow diary, by what date, and how the result reaches the person, and set the same accountability for the challenge test result, the causation letter, the documentation pack, and any report to the state program, so that no document waits on the person to chase it.
• After removal from the agent, keep scheduled reviews with spirometry rather than closing the case, and treat symptoms that continue or worsen despite genuine removal as a reason to reopen the differential, verify that all contact has actually stopped, and reconsider laryngeal obstruction or an interstitial process.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Work-related asthma concentrates in small workplaces and low-wage trades where respiratory protection programs, extraction maintenance, and medical clearance are least likely to exist, so the people most at risk are the least likely to be evaluated. Without paid sick leave, a diary that requires a scheduled two weeks away is impossible unless the clinic writes the leave and helps arrange it. Workers hired through temporary agencies may find that neither the agency nor the host shop treats the hazard as its own to fix, and workers whose right to work is tied to a single employer, or who are the sole earner in a household, weigh consequences for the job against being evaluated at all, which is a reason to be explicit about what each step does and does not set in motion. Cost also decides who is investigated, since a peak flow meter, unpaid leave, and travel to a distant challenge laboratory are all out-of-pocket barriers, and a loaner meter plus a scheduling call removes several of them. Reporting and workplace evaluation exist precisely because individual removal protects one person while leaving the coworkers behind, so the coworker cough mentioned in passing deserves an active invitation rather than a note in the chart.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Reads a normal spirometry result taken after time away from work as uninformative rather than as evidence against work-related asthma.
• Starts controller therapy at the visit where poor control is found, then builds the diagnosis from a serial peak flow diary paired with symptom and reliever records across working and non-working periods.
• Bounds at-work monitoring with a pre-agreed stopping rule, so that deterioration ends the diary and triggers restriction instead of being absorbed by it.
• Interprets specific IgE testing correctly for a low molecular weight chemical agent, treating a positive result as support and a negative result as uninformative rather than exculpatory.
• Weighs the harm of recommending removal from a livelihood against the harm of continued contact and fixed airflow limitation, and gathers the evidence that supports the person either way.
• Extends the plan beyond one person to coworker assessment, hazard control in order of effectiveness, reporting where it applies, and years of surveillance after the causative work has stopped.

Key takeaways#

• Adult-onset asthma that appears months into a job, worsens across the working week, and eases on days away is work-related until proven otherwise, and the loss of that weekend recovery signals disease that has begun to persist.
• Gather the objective evidence while the person is still at work where it is safe to do so, because a serial diary and a challenge performed during a working period are hard to reconstruct later, but stop the at-work arm the moment deterioration is documented, since no diagnostic record is worth the lung function it would cost.
• Sensitizer-induced occupational asthma requires complete removal from the agent rather than reduced contact or a respirator, and removal is the beginning of long-term surveillance rather than the end of the case, since airway hyperresponsiveness often persists.